Studies cite daily needle pain as one of the leading reasons patients do not test blood glucose or inject insulin according to therapeutic recommendations:
“presence of anxiety symptoms was strongly associated with less self-monitoring, fewer daily insulin injections, poorer glycemic control, and a significant increased risk of cardiac and peripheral vascular disease.” - Aronson
- 33% “dreaded” their injections
- 22% had to mentally prepare themselves for injections
- There is a clear relationship between injection pain and more poorly controlled diabetes and U.S. patients who are non-compliant experience worse outcomes and 2x the hospital expense as those who test more frequently.
- Total U.S. estimated costs of diagnosed diabetes have increased 41%, to $245 billion in 2012 from $174 billion in 2007
- 29.1 million Americans, 9.3% of the population, have diabetes
- 21 million Americans have diagnosed diabetes
- 8.1 million Americans have undiagnosed diabetes (27.8% of diabetes is undiagnosed)
- 1.7 million Americans aged 20 years or older are newly diagnosed with diabetes each year, 4,660/day, one every 19 seconds
- 37% of U.S. adults aged 20 years or older have prediabetes
- Almost 30 million children and adults in the United States have diabetes
- 86 million Americans have prediabetes
- 1.7 million Americans are diagnosed with diabetes every year.
- Medical expenditures for people with diabetes are 2.3x higher than for those without diabetes.
- More than 1 in 10 health care dollars in the U.S. are spent directly on diabetes and its complications, and more than 1 in 5 health care dollars in the U.S. goes to the care of people with diagnosed diabetes.
- 387 million people have diabetes; by 2035 this will rise to 592 million
- The number of people with type 2 diabetes is increasing in every country
- 179 million people with diabetes are undiagnosed
- Diabetes caused 4.9 million deaths in 2014
- Every seven seconds a person dies from diabetes
- Diabetes caused at least $612 billion USD dollars in health expenditure in 2014 – 11% of total spending on adults
- More than 79,000 children developed type 1 diabetes in 2013
- More than 21 million live births were affected by diabetes during pregnancy in 2013
Studies to download:
- "Impact of Medication and Adherence on Hospitalization Risk and Healthcare Cost"
- "Injection Impact Survey - Executive Summary"
- "Lack of Compliance with Home Blood Glucose Monitoring Predicts Hospitalization in Diabetes"
- "ADA standards of care suggest changes to BP, glucose monitoring"
See how our product development applies to the diabetic market:
See how the technology works:
1. American Diabetes Association. Economic Costs of Diabetes in the United States in 2012. Diabetes Care 36: 1033—1046, 2013.
2. Aronson, Ronnie. The Role of Comfort and Discomfort in Insulin Therapy. Diabetes Technol Ther. 2012 Aug; 14(8): 741–747. doi: 10.1089/dia.2012.0038
3. Berlin I, Bisserbe JC, Eiber R, Balssa N, Sachon C, Bosquet F, Grimalid A.
Phobic symptoms, particularly the fear of blood and injury, are associated with poor glycemic control in type I diabetic adults. Diabetes Care. 1997 Feb;20(2):176-8.
4. CDC. National Diabetes Statistics Report, 2014. www.cdc.gov. Available at: http://www.cdc.gov/diabetes/pubs/statsreport14/national-diabetes-report-web.pdf.
5. Diabetes Atlas, Sixth Edition: Key Findings 2014. International Diabetes Federation. Available at: http://www.idf.org/diabetesatlas/update-2014. 2014.
6. Hanas R and Ludvigsson J. Experiences of pain from injections and needle phobia in young patients with IDDM. Practical Diabetes July 1997, Vol 14: No 4